A Placebo-controlled, Double-blind, Randomized, Cross Over Pilot Study of the Efficacy and Tolerability of Abobotulinum Toxin A (Dysport) as a Treatment for Task-dependent Upper Limb Tremor
Latest Information Update: 17 Apr 2023
At a glance
- Drugs Botulinum-Toxin-A (Primary)
- Indications Essential tremor
- Focus Therapeutic Use
- 23 Feb 2021 Status changed from active, no longer recruiting to recruiting.
- 29 Apr 2020 Planned End Date changed from 1 Mar 2020 to 1 Dec 2022.
- 29 Apr 2020 Planned primary completion date changed from 1 Mar 2020 to 1 Dec 2022.